EMILY BOWER: Open Payments
NPI 1639805419 · NATICK, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,216 in 96 payments from 15 companies in 2025. Trend: 2023 $1,166 · 2024 $1,335 · 2025 $2,216
Food & beverage: $2,106Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $686 |
| Janssen Biotech, Inc. | 17 | $424 |
| Galderma Laboratories, L.P. | 10 | $275 |
| UCB, Inc. | 9 | $185 |
| Lilly USA, LLC | 8 | $171 |
| E.R. Squibb & Sons, L.L.C. | 6 | $141 |
| ABIOMED | 2 | $125 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Amgen Inc. | 1 | $34 |
| PFIZER INC. | 1 | $33 |
Products named: RINVOQ, TREMFYA, NEMLUVIO, SKYRIZI, Bimzelx, Sotyktu, TALTZ, EBGLYSS.
Industry payments across MA — which companies pay providers there.
